Institute for Research in BiomedicineBarcelona, Spain
CONFERENCE COVERAGE 2012-07-18 Conference Coverage In Alzheimer’s disease drug development, how often does it happen that a large phase 2b trial of an experimental medicine cleanly meets both primary and secondary endpoints as set out in the protocol? Today, at the Alzheimer’s Associat
PAPER Premi E, Garibotto V, Alberici A, Paghera B, Giubbini R, Padovani A, Borroni B
Dement Geriatr Cogn Disord. 2012;33(6):372-8. PubMed: 22797130
PAPER Knight LS, Wenzel HJ, Schwartzkroin PA
Epilepsia. 2012 Jun;53 Suppl 1:161-70. PubMed: 22612821
PAPER Yang M, Kim JS, Kim J, Jang S, Kim SH, Kim JC, Shin T, Wang H, Moon C
Brain Res Bull. 2012 Oct 1;89(1-2):50-6. PubMed: 22796103
PAPER Constant JP, Fraley GS, Forbes E, Hallas BH, Leheste JR, Torres G
Neuroscience. 2012 Oct 11;222:333-42. PubMed: 22796077
PAPER Selenica ML, Brownlow M, Jimenez JP, Lee DC, Pena G, Dickey CA, Gordon MN, Morgan D
Neurodegener Dis. 2012 Jul 10; PubMed: 22796753
PAPER Lang L, Kurnik M, Danielsson J, Oliveberg M
Proc Natl Acad Sci U S A. 2012 Jul 13; PubMed: 22797895
PAPER Yin F, Boveris A, Cadenas E
Antioxid Redox Signal. 2012 Sep 5; PubMed: 22793257
PAPER Castaño Guerrero Y, González Fraguela ME, Fernández Verdecia I, Horruitiner Gutiérrez I, Piedras Carpio S
Neurologia. 2012 Jul 11; PubMed: 22795923
PAPER Chen Y, Zeng Y, Huang R, Yang Y, Chen K, Song W, Zhao B, Li J, Yuan L, Shang HF
Neurobiol Aging. 2012 Nov;33(11):2721.e3-5. PubMed: 22795786
PAPER Kong M, Ba M, Liang H, Ma L, Yu Q, Yu T, Wang Y
Neurosci Lett. 2012 Aug 22;524(1):35-9. PubMed: 22796470
PAPER Permpoonputtana K, Mukda S, Govitrapong P
Neurosci Lett. 2012 Aug 22;524(1):1-4. PubMed: 22796652
PAPER Peters HL, Tuli A, Wang X, Liu C, Pan Z, Ouellette MM, Hollingsworth MA, MacDonald RG, Solheim JC
Int J Oncol. 2012 Jul 13; PubMed: 22797723